Eton Pharmaceuticals (ETON) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $50.31, -1.99% vs the prior close of $51.33.
- Volume 463.24K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ETON dips 2.0% to $50.31, a 1-month low, 4 down days in a row. Closed at $50.31, -1.99% vs the prior close of $51.33. Day range $49.07–$51.87, opened at $51.35.
ETON daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ETON dips 2.0% to $50.31, a 1-month low, 4 down days in a row
- Closed at $50.31, -1.99% vs the prior close of $51.33. Day range $49.07–$51.87, opened at $51.35.
- Volume was 463.24K shares, 0.8x its 50-day average of 615.11K.
- Price is -10.5% vs its 50-day average ($56.21) and +48.1% vs its 200-day average ($33.98).
- 52-week range $14.27–$66.37; today's close sits at 69% of that range, 24.2% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — ETON dips 2.9% to $51.33, a 1-month low, 3 down days in a row
- Closed at $51.33, -2.93% vs the prior close of $52.88. Day range $51.21–$54.89, opened at $53.28.
- Volume was 462.30K shares, 0.8x its 50-day average of 613.64K.
- Price is -8.6% vs its 50-day average ($56.13) and +51.8% vs its 200-day average ($33.81).
- 52-week range $14.27–$66.37; today's close sits at 71% of that range, 22.7% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — ETON dips 0.8% to $52.88
- Closed at $52.88, -0.84% vs the prior close of $53.33. Day range $52.66–$56.42, opened at $53.50.
- Volume was 442.50K shares, 0.7x its 50-day average of 611.63K.
- Price is -5.6% vs its 50-day average ($56.02) and +57.2% vs its 200-day average ($33.64).
- 52-week range $14.27–$66.37; today's close sits at 74% of that range, 20.3% below the 52-week high.
- SEC filings that day: 8-K.
Oct 13, 2026 — ETON slides 3.5% to $53.33
- Closed at $53.33, -3.48% vs the prior close of $55.25. Day range $52.72–$55.54, opened at $55.46.
- Volume was 550.90K shares, 0.9x its 50-day average of 610.02K.
- Price is -4.6% vs its 50-day average ($55.88) and +59.4% vs its 200-day average ($33.46).
- 52-week range $14.27–$66.37; today's close sits at 75% of that range, 19.6% below the 52-week high.
Oct 12, 2026 — ETON ends flat (+0.1%) to $55.25
- Closed at $55.25, +0.07% vs the prior close of $55.21. Day range $55.20–$57.00, opened at $55.50.
- Volume was 436.80K shares, 0.7x its 50-day average of 610.98K.
- Price is -0.8% vs its 50-day average ($55.72) and +66.0% vs its 200-day average ($33.27).
- 52-week range $14.27–$66.37; today's close sits at 79% of that range, 16.8% below the 52-week high.
Oct 9, 2026 — ETON rises 0.8% to $55.21
- Closed at $55.21, +0.84% vs the prior close of $54.75. Day range $54.20–$56.35, opened at $54.86.
- Volume was 371.10K shares, 0.6x its 50-day average of 615.64K.
- Price is -0.6% vs its 50-day average ($55.54) and +66.9% vs its 200-day average ($33.08).
- 52-week range $14.27–$66.37; today's close sits at 79% of that range, 16.8% below the 52-week high.
Oct 8, 2026 — ETON ends flat (-0.2%) to $54.75
- Closed at $54.75, -0.24% vs the prior close of $54.88. Day range $52.70–$55.47, opened at $54.14.
- Volume was 543.40K shares, 0.9x its 50-day average of 618.73K.
- Price is -1.2% vs its 50-day average ($55.42) and +66.5% vs its 200-day average ($32.89).
- 52-week range $14.27–$66.37; today's close sits at 78% of that range, 17.5% below the 52-week high.
Oct 7, 2026 — ETON ends flat (+0.2%) to $54.88
- Closed at $54.88, +0.20% vs the prior close of $54.77. Day range $53.55–$56.42, opened at $53.84.
- Volume was 774.60K shares, 1.2x its 50-day average of 621.06K.
- Price is -0.7% vs its 50-day average ($55.29) and +67.8% vs its 200-day average ($32.70).
- 52-week range $14.27–$66.37; today's close sits at 78% of that range, 17.3% below the 52-week high.
Oct 6, 2026 — ETON dips 1.5% to $54.77
- Closed at $54.77, -1.53% vs the prior close of $55.62. Day range $54.11–$56.15, opened at $56.15.
- Volume was 492.30K shares, 0.8x its 50-day average of 618.52K.
- Price is -0.6% vs its 50-day average ($55.12) and +68.5% vs its 200-day average ($32.50).
- 52-week range $14.27–$66.37; today's close sits at 78% of that range, 17.5% below the 52-week high.
Oct 5, 2026 — ETON rises 0.5% to $55.62, 3 up days in a row
- Closed at $55.62, +0.47% vs the prior close of $55.36. Day range $54.50–$56.86, opened at $55.85.
- Volume was 405.40K shares, 0.7x its 50-day average of 618.13K.
- Price is +1.4% vs its 50-day average ($54.87) and +72.2% vs its 200-day average ($32.31).
- 52-week range $14.27–$66.37; today's close sits at 79% of that range, 16.2% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — ETON jumps 6.5% to $55.36
- Closed at $55.36, +6.50% vs the prior close of $51.98. Day range $52.00–$56.00, opened at $52.42.
- Volume was 750.10K shares, 1.2x its 50-day average of 614.55K.
- Price is +1.4% vs its 50-day average ($54.61) and +72.4% vs its 200-day average ($32.11).
- 52-week range $14.27–$66.37; today's close sits at 79% of that range, 16.6% below the 52-week high.
ETON latest news & SEC filings
Every SEC filing by or about ETON in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.01 — Completed an acquisition or sale of assets.
Oct 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Krempa David converted options/RSUs into 10,522 shares on Oct 2, 2026; now holds 47,547
- Krempa David sold 4,166 shares at $55.07 (≈$229.41K) on Oct 6, 2026; now holds 43,381
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 6, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 31, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Maier Paul V sold 13,485 shares at $60.21 (≈$811.93K) on Aug 28, 2026
- Maier Paul V sold 128 shares at $61.77 (≈$7.91K) on Aug 28, 2026
- Maier Paul V sold 36,387 shares at $58.64 (≈$2.13M) on Aug 28, 2026
- Maier Paul V sold 13,485 shares at $60.21 (≈$811.93K) on Aug 28, 2026
- Maier Paul V sold 128 shares at $61.77 (≈$7.91K) on Aug 28, 2026
- Maier Paul V sold 36,387 shares at $58.64 (≈$2.13M) on Aug 28, 2026
- …plus 6 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Maier Paul V sold 128 shares at $61.77 (≈$7.91K) on Aug 28, 2026
- Maier Paul V sold 13,485 shares at $60.21 (≈$811.93K) on Aug 28, 2026
- Maier Paul V sold 36,387 shares at $58.64 (≈$2.13M) on Aug 28, 2026
- Maier Paul V sold 128 shares at $61.77 (≈$7.91K) on Aug 28, 2026
- Maier Paul V sold 13,485 shares at $60.21 (≈$811.93K) on Aug 28, 2026
- Maier Paul V sold 36,387 shares at $58.64 (≈$2.13M) on Aug 28, 2026
- …plus 6 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Krempa David sold 25,000 shares at $65.07 (≈$1.63M) on Aug 24, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $37.59M (prior year $18.93M) (+98.6% vs Jun 30, 2025)
- Net income: $11.58M (prior year -$2.58M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.35 (prior year -$0.10) (swung to profit vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.01 — Completed an acquisition or sale of assets.
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 28, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade ETON
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 19, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.59% (largest 13.0%).
- Liquidity: about 621.29K shares (≈$31.26M) trade per day on average.
- 52-week position: $50.31 vs a range of $14.27–$66.37 (69% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Paul V Maier sold 13,485 shares on Aug 28, 2026.
- Latest filings: 8-K Oct 14, 2026; 8-K Sep 28, 2026; 10-Q Aug 13, 2026.
- Share count: 28.58M shares outstanding (Aug 11, 2026), +6.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ETON market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 51.35 | 51.87 | 49.07 | 50.31 | 463.24K |
| Oct 15, 2026 | 53.28 | 54.89 | 51.21 | 51.33 | 462.30K |
| Oct 14, 2026 | 53.50 | 56.42 | 52.66 | 52.88 | 442.50K |
| Oct 13, 2026 | 55.46 | 55.54 | 52.72 | 53.33 | 550.90K |
| Oct 12, 2026 | 55.50 | 57.00 | 55.20 | 55.25 | 436.80K |
| Oct 9, 2026 | 54.86 | 56.35 | 54.20 | 55.21 | 371.10K |
| Oct 8, 2026 | 54.14 | 55.47 | 52.70 | 54.75 | 543.40K |
| Oct 7, 2026 | 53.84 | 56.42 | 53.55 | 54.88 | 774.60K |
| Oct 6, 2026 | 56.15 | 56.15 | 54.11 | 54.77 | 492.30K |
| Oct 5, 2026 | 55.85 | 56.86 | 54.50 | 55.62 | 405.40K |
| Oct 2, 2026 | 52.42 | 56.00 | 52.00 | 55.36 | 750.10K |
| Oct 1, 2026 | 50.18 | 54.00 | 49.67 | 51.98 | 1.33M |
| Sep 30, 2026 | 59.61 | 59.66 | 48.79 | 51.49 | 1.81M |
| Sep 29, 2026 | 58.88 | 59.73 | 57.90 | 59.19 | 710.60K |
| Sep 28, 2026 | 57.68 | 59.72 | 56.01 | 59.18 | 390.30K |
| Sep 25, 2026 | 60.00 | 60.60 | 57.23 | 57.68 | 514.40K |
| Sep 24, 2026 | 56.19 | 59.62 | 55.34 | 59.49 | 725.40K |
| Sep 23, 2026 | 56.96 | 56.97 | 54.24 | 55.61 | 436.10K |
| Sep 22, 2026 | 55.31 | 57.50 | 55.01 | 57.09 | 484.00K |
| Sep 21, 2026 | 55.50 | 56.75 | 53.60 | 55.31 | 335.50K |
About Eton Pharmaceuticals
Eton Pharmaceuticals (ETON) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in DEER PARK, IL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1710340.
ETON board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jennifer Mckie Adams | Director | Aug 4, 2026 |
| Sean Brynjelsen | President & CEO | Aug 20, 2026 |
| Charles J Casamento | Director | Aug 4, 2026 |
| Paul V Maier | Director | Aug 31, 2026 |
| Norbert G Riedel | Director | Aug 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Sean Brynjelsen | President & CEO | Aug 20, 2026 |
| Ipek Erdogan-Trinkaus | Chief Commercial Officer | Aug 4, 2026 |
| James R. Gruber | Chief Financial Officer | Jan 14, 2026 |
| David Krempa | Chief Business Officer | Aug 24, 2026 |
| Judith M. Matthews | Chief Financial Officer | Aug 4, 2026 |
| Danka Radosavljevic | Chief Operating Officer | Aug 12, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 28, 2026 | Paul V Maier | Sale | 13,485 | $60.21 |
| Aug 28, 2026 | Paul V Maier | Sale | 128 | $61.77 |
| Aug 28, 2026 | Paul V Maier | Sale | 36,387 | $58.64 |
| Aug 28, 2026 | Paul V Maier | Sale | 13,485 | $60.21 |
| Aug 28, 2026 | Paul V Maier | Sale | 128 | $61.77 |
| Aug 28, 2026 | Paul V Maier | Sale | 36,387 | $58.64 |
| Aug 28, 2026 | Paul V Maier | Sale | 13,485 | $60.21 |
| Aug 28, 2026 | Paul V Maier | Sale | 128 | $61.77 |
| Aug 28, 2026 | Paul V Maier | Sale | 36,387 | $58.64 |
| Aug 28, 2026 | Paul V Maier | Sale | 13,485 | $60.21 |
| Aug 28, 2026 | Paul V Maier | Sale | 128 | $61.77 |
| Aug 28, 2026 | Paul V Maier | Sale | 36,387 | $58.64 |
| Aug 28, 2026 | Paul V Maier | Sale | 128 | $61.77 |
| Aug 28, 2026 | Paul V Maier | Sale | 13,485 | $60.21 |
| Aug 28, 2026 | Paul V Maier | Sale | 36,387 | $58.64 |
ETON financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $79.95M | $-4.60M | -0.17 | $10.52M |
| Dec 31, 2024 | $39.01M | $-3.82M | -0.15 | $969.00K |
| Dec 31, 2023 | $31.64M | $-936.00K | -0.04 | $6.82M |
| Dec 31, 2022 | $21.25M | $-9.02M | -0.36 | $4.82M |
| Dec 31, 2021 | $21.83M | $-1.96M | -0.08 | $-4.72M |
Latest balance sheet: total assets $115.81M, total liabilities $69.22M, cash $26.84M (as of Jun 30, 2026).
ETON earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $40.80 |
| May 14, 2026 | 8-K Item 2.02 (results) | $29.96 |
| Mar 19, 2026 | 8-K Item 2.02 (results) | $20.77 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $19.14 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $15.26 |
| May 13, 2025 | 8-K Item 2.02 (results) | $17.07 |
| Mar 18, 2025 | 8-K Item 2.02 (results) | $14.68 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $9.17 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 14, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ETON
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.